Blake Shockley, MD
Orthopaedic Surgery · Tulsa, OKNPI 1942349758
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 97.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $20,699 and has fallen 94.0% since, to $1,232 in 2025.
Across 155 payments — averaging $250.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$38K
- Stryker$529
- Zimmer Biomet$147
- Vericel Corporation$60
- Vertex$43
- Johnson & Johnson$39
- plus $59 from 2 others
What the payments were for
- Consulting fees$9,52725%
- Speaking & faculty fees$19,01849%
- Travel & lodging$4,96213%
- Food & beverage$5,33314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 135 | $37,963 |
| Stryker | 9 | $529 |
| Zimmer Biomet | 1 | $147 |
| Vericel Corporation | 3 | $60 |
| Vertex | 2 | $43 |
| Johnson & Johnson | 2 | $39 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Pylant Medical | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$8,297
- Regeneten$7,621
- BIOSURE REGENESORB$4,916
- Ambient Wands$3,656
- WEREWOLF$3,656
- Dyonics Platinum$2,904
- DYONICS 25$2,766
- Dyonics Electroblade$2,766
- PROCISE Tonsil$1,129
- HEALICOIL PK Hip$1,129
- DERMAL WOUND$1,129
- Journey II$1,129
- EVOS$1,129
- Coblation Wands$695
- BIORAPTOR$624
- Q-FIX$624
- FOOTPRINT$624
- Healicoil$624
- Firstpass$624
- REGENETEN Shoulder$457
How this compares
$38,841 in reported general payments places this provider in the 85th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $3,276 |
| Celecoxib | 38 | $545 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $439 |
| Diclofenac Sodium | 40 | $409 |
| Meloxicam | 39 | $259 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 52 | $255 |
| Promethazine Hcl | 53 | $180 |
| Gabapentin | 77 | $135 |
| Methylprednisolone | 15 | $99 |
| Prednisone | 16 | $55 |
| Cyclobenzaprine Hcl | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.6M
- Brian ChalkinTulsa$183K
- Kasra AhmadiniaTulsa$138K
- Sarat KunapuliTulsa$136K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Chad CrawleyTulsa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.